title: The legacy effect: 4.5 years of a chlorthalidone-based antihypertensive regimen reduces cardiovascular mortality and prolongs cardiovascular disease-free survival at 22 years for older patients with isolated systolic hypertension.
authors.affiliation: Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. gsmetana@bidmc.harvard.edu
authors.forename: Gerald William
authors.initials: GW
authors.lastname: Smetana